Bezopasnost' kombinirovannoy terapii SD tipa 2: printsip vnedorozhnika
- Authors: Aleksandrov A.A1, Yadrikhinskaya M.N1, Kukharenko S.S1, Shatskaya O.A1, Abdalkina E.N2
-
Affiliations:
- ФГБУ Эндокринологический научный центр Минздрава РФ, Москва
- НОУ ВПО Самарский медицинский институт «РЕАВИЗ»
- Issue: Vol 15, No 5 (2013)
- Pages: 63-66
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/93883
- ID: 93883
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. A Aleksandrov
ФГБУ Эндокринологический научный центр Минздрава РФ, МоскваКардиологическое отделение
M. N Yadrikhinskaya
ФГБУ Эндокринологический научный центр Минздрава РФ, МоскваКардиологическое отделение
S. S Kukharenko
ФГБУ Эндокринологический научный центр Минздрава РФ, МоскваКардиологическое отделение
O. A Shatskaya
ФГБУ Эндокринологический научный центр Минздрава РФ, МоскваКардиологическое отделение
E. N Abdalkina
НОУ ВПО Самарский медицинский институт «РЕАВИЗ»Кафедра клинической медицины
References
- Monami M, Luzzi C, Chiasserini V et al. Three - year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin. Diabetes Metab Res Rev 2006; 22: 477–82.
- Matsuo M, Ueda K, Ryder K, Ashcroft F. The sulphonylurea receptor: An ABCC transporter that acts as an ion channel regulator. In: Holland, IB ed. ABC proteins. Academic Press 2003; 551–76.
- Proks P, Lippiat J.D. Membrane ion channels and diabetes. Curr Pharm Des 2006; 12: 485–501.
- Sukhodub A, Jovanovic S, Du Q et al. AMP - activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP - sensitive K+channels. J Cell Physiol 2007; 210: 224–36.
- Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 1999; 61: 337–62.
- Shi N.Q, Ye B, Makielski J.C. Function and distribution of the SUR isoforms and splice variants. J Mol Cell Cardiol 2005; 39: 51–60.
- Proks P, Lippiat J.D. Membrane ion channels and diabetes. Curr Pharm Des 2006; 12: 485–501.
- Aguilar-Bryan L, Nichols C.G, Wechsler S.W et al. Cloning of the beta cell high - affinity sulfonylurea receptor: a regulator of insulin secretion. Sci 1995; 268: 423–6.
- Michael A, Burke R. Kannan Mutharasan and Hossein Ardehali. The Sulfonylurea Receptor, an Atypical ATP - Binding Cassette Protein, and Its Regulation of the K ATP Channel. Circ Res 2008; 102: 164–76.
- Ardehali H, O’Rourke B. Mitochondrial K (ATP) channels in cell survival and death. J Mol Cell Cardiol 2005; 39: 7–16.
- Ardehali H, O’Rourke B. Mitochondrial K (ATP) channels in cell survival and death. J Mol Cell Cardiol 2005; 39: 7–16.
- Proks P, Reimann F, Green N et al. Sulfonylurea stimulation of insulin secretion. Diabetes 2002; 51 (Suppl. 3): S368–S376.
- Quat U, Stephan D, Bieger S, Russ U. The impact of ATP - sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes 2004; 53 (Suppl. 3): S156–S164.
- Ogawa K, Ikewaki K, Taniguchi I et al. Mitiglinide, a novel oral hypoglycemic agent, preserves the cardioprotective effect of ischemic preconditioning in isolated perfused rat hearts. Int Heart J 2007; 48: 337–45.
- Mocanu M.M, Maddock H.L, Baxter G.F et al. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation 2001; 103: 3111–6.
- Thisted H, Johnsen S.P, Rungby J. Sulfonylureas and the risk of myocardial infarction. Metabolism 2006; 55: S16–S19.
- Александров А.А. Сердечно - сосудистые осложнения и современный алгоритм сахароснижающей терапии: «Флорентийская перспектива». РМЖ (Эндокринология). 2010; 18 (14).
- Zhou G, Myers R, Li Y et al. Role of AMP - activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167–74.